Cargando…
Secretory co-factors in next-generation cellular therapies for cancer
Since chimeric antigen receptor (CAR) T-cell therapies for hematologic malignancies were approved by the U.S. Food and Drug Administration, numerous “next-generation” CAR T cells have been developed to improve their safety, efficacy, and applicability. Although some of these novel therapeutic strate...
Autores principales: | Okuma, Atsushi, Ishida, Yoshihito, Kawara, Taketo, Hisada, Shoji, Araki, Shinsuke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9433659/ https://www.ncbi.nlm.nih.gov/pubmed/36059449 http://dx.doi.org/10.3389/fimmu.2022.907022 |
Ejemplares similares
-
MAOI Antidepressants: Could They Be a Next-Generation ICB Therapy?
por: Brown, James, et al.
Publicado: (2022) -
Leukemia’s Next Top Model? Syngeneic Models to Advance Adoptive Cellular Therapy
por: Zoine, Jaquelyn T., et al.
Publicado: (2022) -
Editorial: Next generation B cell targeting therapies in autoimmune diseases
por: Li, Rui, et al.
Publicado: (2023) -
Editorial: Next generation MSC therapy manufacturing, potency and mechanism of action analysis
por: Chinnadurai, Raghavan, et al.
Publicado: (2023) -
Next-Generation Sequencing of Antibody Display Repertoires
por: Rouet, Romain, et al.
Publicado: (2018)